EMCURE PHARMACEUTICALS
|
EMCURE PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EQUITY AND LIABILITIES | |||||
| Share Capital | ₹189 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr |
| Equity - Authorised | ₹250 Cr | ₹250 Cr | ₹250 Cr | ₹200 Cr | ₹200 Cr |
| Equity - Issued | ₹189 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr |
| Equity Paid Up | ₹189 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr | ₹181 Cr |
| Equity Shares Forfeited | - | - | - | - | - |
| Adjustments to Equity | - | - | - | - | - |
| Preference Capital Paid Up | - | - | - | - | - |
| Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
| Share Warrants & Outstandings | ₹12 Cr | ₹14 Cr | ₹15 Cr | ₹16 Cr | ₹12 Cr |
| Total Reserves | ₹4,245 Cr | ₹2,757 Cr | ₹2,305 Cr | ₹1,791 Cr | ₹2,080 Cr |
| Securities Premium | ₹785 Cr | ₹9.88 Cr | - | - | ₹84 Cr |
| Capital Reserves | - | - | - | - | ₹1.29 Cr |
| Profit & Loss Account Balance | ₹3,313 Cr | ₹2,634 Cr | ₹2,196 Cr | ₹1,695 Cr | ₹1,744 Cr |
| General Reserves | ₹64 Cr | ₹64 Cr | ₹82 Cr | ₹80 Cr | ₹175 Cr |
| Other Reserves | ₹83 Cr | ₹49 Cr | ₹27 Cr | ₹16 Cr | ₹76 Cr |
| Reserve excluding Revaluation Reserve | ₹4,245 Cr | ₹2,757 Cr | ₹2,305 Cr | ₹1,791 Cr | ₹2,080 Cr |
| Revaluation reserve | - | - | - | - | - |
| Shareholder's Funds | ₹4,446 Cr | ₹2,952 Cr | ₹2,501 Cr | ₹1,988 Cr | ₹2,273 Cr |
| Minority Interest | ₹195 Cr | ₹169 Cr | ₹149 Cr | ₹127 Cr | ₹95 Cr |
| Long-Term Borrowings | - | - | - | - | - |
| Secured Loans | ₹186 Cr | ₹761 Cr | ₹737 Cr | ₹709 Cr | ₹694 Cr |
| Non Convertible Debentures | - | - | - | - | - |
| Converible Debentures & Bonds | - | - | - | - | - |
| Packing Credit - Bank | - | - | - | - | - |
| Inter Corporate & Security Deposit | - | - | - | - | - |
| Term Loans - Banks | ₹255 Cr | ₹930 Cr | ₹677 Cr | ₹679 Cr | ₹686 Cr |
| Term Loans - Institutions | - | ₹204 Cr | ₹359 Cr | ₹296 Cr | ₹357 Cr |
| Other Secured | ₹-68 Cr | ₹-372 Cr | ₹-299 Cr | ₹-266 Cr | ₹-350 Cr |
| Unsecured Loans | ₹3.53 Cr | ₹5.24 Cr | ₹6.90 Cr | ₹8.54 Cr | ₹10 Cr |
| Fixed Deposits - Public | - | - | - | - | - |
| Loans and advances from subsidiaries | - | - | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
| Foreign Currency Convertible Notes | - | - | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - | - | - |
| Loans - Banks | - | - | - | - | - |
| Loans - Govt. | - | - | - | - | - |
| Loans - Others | ₹3.53 Cr | ₹5.24 Cr | ₹6.90 Cr | ₹8.54 Cr | ₹10 Cr |
| Other Unsecured Loan | - | - | - | - | - |
| Deferred Tax Assets / Liabilities | ₹9.04 Cr | ₹41 Cr | ₹-60 Cr | ₹-73 Cr | ₹-108 Cr |
| Deferred Tax Assets | ₹251 Cr | ₹210 Cr | ₹173 Cr | ₹206 Cr | ₹260 Cr |
| Deferred Tax Liability | ₹260 Cr | ₹251 Cr | ₹113 Cr | ₹132 Cr | ₹151 Cr |
| Other Long Term Liabilities | ₹565 Cr | ₹527 Cr | ₹181 Cr | ₹182 Cr | ₹221 Cr |
| Long Term Trade Payables | - | - | - | - | - |
| Long Term Provisions | ₹48 Cr | ₹43 Cr | ₹40 Cr | ₹42 Cr | ₹66 Cr |
| Total Non-Current Liabilities | ₹812 Cr | ₹1,377 Cr | ₹905 Cr | ₹868 Cr | ₹883 Cr |
| Current Liabilities | - | - | - | - | - |
| Trade Payables | ₹1,480 Cr | ₹1,309 Cr | ₹1,086 Cr | ₹1,125 Cr | ₹972 Cr |
| Sundry Creditors | ₹1,480 Cr | ₹1,309 Cr | ₹1,086 Cr | ₹1,125 Cr | ₹972 Cr |
| Acceptances | - | - | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - | - | - |
| Other Current Liabilities | ₹548 Cr | ₹855 Cr | ₹712 Cr | ₹649 Cr | ₹972 Cr |
| Bank Overdraft / Short term credit | - | - | - | - | - |
| Advances received from customers | ₹12 Cr | ₹33 Cr | ₹17 Cr | ₹15 Cr | ₹12 Cr |
| Interest Accrued But Not Due | ₹1.01 Cr | ₹15 Cr | ₹13 Cr | ₹6.36 Cr | ₹11 Cr |
| Share Application Money | - | - | - | - | - |
| Current maturity of Debentures & Bonds | - | - | - | - | - |
| Current maturity - Others | - | - | - | - | - |
| Other Liabilities | ₹536 Cr | ₹807 Cr | ₹682 Cr | ₹627 Cr | ₹949 Cr |
| Short Term Borrowings | ₹474 Cr | ₹947 Cr | ₹1,132 Cr | ₹1,085 Cr | ₹1,253 Cr |
| Secured ST Loans repayable on Demands | ₹475 Cr | ₹949 Cr | ₹1,132 Cr | ₹1,085 Cr | ₹1,247 Cr |
| Working Capital Loans- Sec | ₹475 Cr | ₹949 Cr | ₹1,132 Cr | ₹1,062 Cr | ₹1,247 Cr |
| Buyers Credits - Unsec | - | - | - | - | - |
| Commercial Borrowings- Unsec | - | - | - | - | - |
| Other Unsecured Loans | ₹-476 Cr | ₹-950 Cr | ₹-1,132 Cr | ₹-1,062 Cr | ₹-1,241 Cr |
| Short Term Provisions | ₹167 Cr | ₹99 Cr | ₹89 Cr | ₹106 Cr | ₹211 Cr |
| Proposed Equity Dividend | - | - | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - | - | - |
| Provision for Tax | ₹112 Cr | ₹53 Cr | ₹49 Cr | ₹62 Cr | ₹62 Cr |
| Provision for post retirement benefits | - | - | - | - | - |
| Preference Dividend | - | - | - | - | - |
| Other Provisions | ₹55 Cr | ₹46 Cr | ₹40 Cr | ₹44 Cr | ₹150 Cr |
| Total Current Liabilities | ₹2,668 Cr | ₹3,210 Cr | ₹3,019 Cr | ₹2,965 Cr | ₹3,408 Cr |
| Total Liabilities | ₹8,122 Cr | ₹7,709 Cr | ₹6,573 Cr | ₹5,947 Cr | ₹6,659 Cr |
| ASSETS | |||||
| Gross Block | ₹5,485 Cr | ₹5,092 Cr | ₹3,802 Cr | ₹3,472 Cr | ₹3,932 Cr |
| Less: Accumulated Depreciation | ₹2,288 Cr | ₹1,968 Cr | ₹1,656 Cr | ₹1,428 Cr | ₹1,476 Cr |
| Less: Impairment of Assets | - | - | - | - | ₹44 Cr |
| Net Block | ₹3,197 Cr | ₹3,125 Cr | ₹2,147 Cr | ₹2,044 Cr | ₹2,412 Cr |
| Lease Adjustment A/c | - | - | - | - | - |
| Capital Work in Progress | ₹124 Cr | ₹132 Cr | ₹404 Cr | ₹310 Cr | ₹222 Cr |
| Non Current Investments | ₹19 Cr | ₹18 Cr | ₹25 Cr | ₹25 Cr | ₹0.00 Cr |
| Long Term Investment | ₹19 Cr | ₹18 Cr | ₹25 Cr | ₹25 Cr | ₹0.00 Cr |
| Quoted | - | - | - | - | - |
| Unquoted | ₹19 Cr | ₹18 Cr | ₹25 Cr | ₹25 Cr | ₹0.00 Cr |
| Long Term Loans & Advances | ₹161 Cr | ₹144 Cr | ₹114 Cr | ₹112 Cr | ₹219 Cr |
| Other Non Current Assets | ₹12 Cr | ₹3.75 Cr | ₹40 Cr | ₹22 Cr | ₹8.53 Cr |
| Total Non-Current Assets | ₹3,566 Cr | ₹3,449 Cr | ₹2,737 Cr | ₹2,523 Cr | ₹2,942 Cr |
| Current Assets Loans & Advances | - | - | - | - | - |
| Currents Investments | ₹76 Cr | ₹300 Cr | - | - | - |
| Quoted | ₹76 Cr | ₹39 Cr | - | - | - |
| Unquoted | - | ₹260 Cr | - | - | - |
| Inventories | ₹1,932 Cr | ₹1,525 Cr | ₹1,383 Cr | ₹1,449 Cr | ₹1,514 Cr |
| Raw Materials | ₹447 Cr | ₹323 Cr | ₹379 Cr | ₹420 Cr | ₹402 Cr |
| Work-in Progress | ₹265 Cr | ₹253 Cr | ₹152 Cr | ₹155 Cr | ₹154 Cr |
| Finished Goods | ₹319 Cr | ₹235 Cr | ₹194 Cr | ₹231 Cr | ₹204 Cr |
| Packing Materials | ₹102 Cr | ₹98 Cr | ₹103 Cr | ₹72 Cr | ₹63 Cr |
| Stores  and Spare | ₹96 Cr | ₹81 Cr | ₹66 Cr | ₹57 Cr | ₹38 Cr |
| Other Inventory | ₹703 Cr | ₹534 Cr | ₹489 Cr | ₹514 Cr | ₹653 Cr |
| Sundry Debtors | ₹2,002 Cr | ₹1,859 Cr | ₹1,648 Cr | ₹1,309 Cr | ₹1,475 Cr |
| Debtors more than Six months | ₹230 Cr | ₹241 Cr | ₹181 Cr | ₹152 Cr | ₹49 Cr |
| Debtors Others | ₹1,868 Cr | ₹1,681 Cr | ₹1,517 Cr | ₹1,195 Cr | ₹1,475 Cr |
| Cash and Bank | ₹165 Cr | ₹232 Cr | ₹458 Cr | ₹313 Cr | ₹524 Cr |
| Cash in hand | ₹0.11 Cr | ₹0.16 Cr | ₹0.18 Cr | ₹0.12 Cr | ₹0.39 Cr |
| Balances at Bank | ₹165 Cr | ₹232 Cr | ₹458 Cr | ₹313 Cr | ₹523 Cr |
| Other cash and bank balances | - | - | - | - | - |
| Other Current Assets | ₹85 Cr | ₹99 Cr | ₹79 Cr | ₹86 Cr | ₹34 Cr |
| Interest accrued on Investments | - | - | - | - | ₹1.13 Cr |
| Interest accrued on Debentures | - | - | - | - | - |
| Deposits with Government | - | - | - | - | - |
| Interest accrued and or due on loans | - | - | - | - | - |
| Prepaid Expenses | ₹33 Cr | ₹30 Cr | ₹20 Cr | ₹33 Cr | ₹16 Cr |
| Other current_assets | ₹53 Cr | ₹69 Cr | ₹59 Cr | ₹53 Cr | ₹17 Cr |
| Short Term Loans and Advances | ₹295 Cr | ₹239 Cr | ₹268 Cr | ₹267 Cr | ₹170 Cr |
| Advances recoverable in cash or in kind | ₹63 Cr | ₹68 Cr | ₹84 Cr | ₹115 Cr | ₹47 Cr |
| Advance income tax and TDS | - | - | - | - | - |
| Amounts due from directors | - | - | - | - | - |
| Due From Subsidiaries | - | - | - | - | - |
| Inter corporate deposits | - | - | - | - | - |
| Corporate Deposits | - | - | - | - | - |
| Other Loans & Advances | ₹233 Cr | ₹171 Cr | ₹184 Cr | ₹151 Cr | ₹123 Cr |
| Total Current Assets | ₹4,556 Cr | ₹4,254 Cr | ₹3,836 Cr | ₹3,424 Cr | ₹3,717 Cr |
| Net Current Assets (Including Current Investments) | ₹1,888 Cr | ₹1,044 Cr | ₹817 Cr | ₹459 Cr | ₹309 Cr |
| Miscellaneous Expenses not written off | - | - | - | - | - |
| Total Assets | ₹8,122 Cr | ₹7,709 Cr | ₹6,573 Cr | ₹5,947 Cr | ₹6,659 Cr |
| Contingent Liabilities | ₹394 Cr | ₹286 Cr | ₹97 Cr | ₹12 Cr | ₹13 Cr |
| Total Debt | ₹731 Cr | ₹2,072 Cr | ₹2,182 Cr | ₹2,077 Cr | ₹2,310 Cr |
| Book Value | 234.02 | 162.17 | 137.48 | 109.02 | 125.04 |
| Adjusted Book Value | 234.02 | 162.17 | 137.48 | 109.02 | 125.04 |
Compare Balance Sheet of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹26,387.6 Cr | -0.4% | 5.6% | 5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,412.0 Cr | -0.4% | 6.4% | 4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,343.0 Cr | -1.5% | -4.9% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,191.0 Cr | -0.7% | 4.8% | 16.6% | Stock Analytics | |
| CIPLA | ₹122,511.0 Cr | -0.5% | 1% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,523.0 Cr | 2.2% | 6.6% | 5.7% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.4% |
5.6% |
5% |
| SENSEX | 0.7% |
0.9% |
6.1% |
You may also like the below Video Courses